https://www.selleckchem.com/pr....oducts/pd0166285.htm
Antipsychotic polypharmacy ("polypharmacy" involves the concurrent prescribing of two or more antipsychotics for managing schizophrenia. It occurs frequently despite there being limited clinical evidence for this practice and an increased risk of adverse events. Little is understood about why it occurs outside of treatment guidelines, highlighting a current research gap. To explore the factors contributing to non-evidence based polypharmacy practice and possible strategies for addressing these factors. Three focus groups were conduct
Curtir
Comentario
Compartilhar
